Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
Applications Due:
Closed
Federal
US Department of Health & Human Services (National Institutes of Health)
Description
The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Small businesses, Nonprofits
Funding
Program Funding
Award Ceiling
Award Floor
Award Count
Timing
Posted Date
December 23, 2022
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
NIH Grants Information
Contact Email
Contact Phone